411 related articles for article (PubMed ID: 26173719)
21. Attitudes to participation in a lung cancer screening trial: a qualitative study.
Patel D; Akporobaro A; Chinyanganya N; Hackshaw A; Seale C; Spiro SG; Griffiths C;
Thorax; 2012 May; 67(5):418-25. PubMed ID: 22106018
[TBL] [Abstract][Full Text] [Related]
22. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study.
Prout HC; Barham A; Bongard E; Tudor-Edwards R; Griffiths G; Hamilton W; Harrop E; Hood K; Hurt CN; Nelson R; Porter C; Roberts K; Rogers T; Thomas-Jones E; Tod A; Yeo ST; Neal RD; Nelson A
Trials; 2018 Aug; 19(1):419. PubMed ID: 30075741
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China].
Wen Y; Yu LZ; Du LB; Wei DH; Liu YY; Yang ZY; Zheng YD; Wu Z; Yu XY; Zhao L; Yu YW; Chen HD; Ren JS; Qin C; Xu YJ; Cao W; Wang F; Li J; Tan FW; Dai M; Chen WQ; Li N; He J
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 May; 55(5):633-639. PubMed ID: 34034404
[No Abstract] [Full Text] [Related]
24. [Risk factors for lung cancer based on low-dose computed tomography screening].
Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
[No Abstract] [Full Text] [Related]
25. The influence of selected factors on the attendance of the high-risk population in the early lung cancer detection program.
Zakrzewska A; Szczepanowska M; Książek J; Biadacz I; Dziedzic R; Jelitto-Górska M; Rzyman W
Pneumonol Alergol Pol; 2014; 82(1):25-31. PubMed ID: 24391068
[TBL] [Abstract][Full Text] [Related]
26. Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial.
Crosbie PAJ; Gabe R; Simmonds I; Hancock N; Alexandris P; Kennedy M; Rogerson S; Baldwin D; Booton R; Bradley C; Darby M; Eckert C; Franks KN; Lindop J; Janes SM; Møller H; Murray RL; Neal RD; Quaife SL; Upperton S; Shinkins B; Tharmanathan P; Callister MEJ
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35777775
[TBL] [Abstract][Full Text] [Related]
27. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.
Crosbie PA; Gabe R; Simmonds I; Kennedy M; Rogerson S; Ahmed N; Baldwin DR; Booton R; Cochrane A; Darby M; Franks K; Hinde S; Janes SM; Macleod U; Messenger M; Moller H; Murray RL; Neal RD; Quaife SL; Sculpher M; Tharmanathan P; Torgerson D; Callister ME
BMJ Open; 2020 Sep; 10(9):e037075. PubMed ID: 32912947
[TBL] [Abstract][Full Text] [Related]
28. The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer.
Usher-Smith JA; Godoy A; Burge SW; Burbidge S; Cartledge J; Crosbie PAJ; Eckert C; Farquhar F; Hammond D; Hancock N; Iball GR; Kimuli M; Masson G; Neal RD; Rogerson S; Rossi SH; Sala E; Smith A; Sharp SJ; Simmonds I; Wallace T; Ward M; Callister MEJ; Stewart GD
BMJ Open; 2022 Sep; 12(9):e063018. PubMed ID: 36127097
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.
Oudkerk M; Liu S; Heuvelmans MA; Walter JE; Field JK
Nat Rev Clin Oncol; 2021 Mar; 18(3):135-151. PubMed ID: 33046839
[TBL] [Abstract][Full Text] [Related]
30. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
Spiro SG; Shah PL; Rintoul RC; George J; Janes S; Callister M; Novelli M; Shaw P; Kocjan G; Griffiths C; Falzon M; Booton R; Magee N; Peake M; Dhillon P; Sridharan K; Nicholson AG; Padley S; Taylor MN; Ahmed A; Allen J; Ngai Y; Chinyanganya N; Ashford-Turner V; Lewis S; Oukrif D; Rabbitts P; Counsell N; Hackshaw A
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31537697
[TBL] [Abstract][Full Text] [Related]
31. LUCSO-1-French pilot study of LUng Cancer Screening with low-dose computed tomography in a smokers population exposed to Occupational lung carcinogens: study protocol.
Delva F; Laurent F; Paris C; Belacel M; Brochard P; Bylicki O; Chouaïd C; Clin B; Dewitte JD; Le Denmat V; Gehanno JF; Lacourt A; Margery J; Verdun-Esquer C; Mathoulin-Pélissier S; Pairon JC
BMJ Open; 2019 Mar; 9(3):e025026. PubMed ID: 30904859
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of Lung Cancer Screening in Canada.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
[TBL] [Abstract][Full Text] [Related]
33. Implementation of targeted screening for lung cancer in a high-risk population within routine NHS practice using low-dose computed tomography.
Grover H; Ross T; Fuller E
Thorax; 2020 Apr; 75(4):348-350. PubMed ID: 32127463
[TBL] [Abstract][Full Text] [Related]
34. Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.
Pinsky PF; Kramer BS
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26483244
[TBL] [Abstract][Full Text] [Related]
35. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program.
Moizs M; Bajzik G; Lelovics Z; Strausz J; Rakvács M; Zádori P; Kovács Á; Repa I
Pathol Oncol Res; 2015 Sep; 21(4):1167-73. PubMed ID: 26003189
[TBL] [Abstract][Full Text] [Related]
37. Tracking the Nonenrolled: Lung Cancer Screening Patterns Among Individuals not Accrued to a Clinical Trial.
Gerber DE; Hamann HA; Chavez C; Dorsey O; Santini NO; Browning T; Ochoa CD; Adesina J; Natchimuthu VS; Steen E; Zhu H; Lee SJC
Clin Lung Cancer; 2020 Jul; 21(4):326-332. PubMed ID: 32184050
[TBL] [Abstract][Full Text] [Related]
38. Understanding the decision to screen for lung cancer or not: A qualitative analysis.
Draucker CB; Rawl SM; Vode E; Carter-Harris L
Health Expect; 2019 Dec; 22(6):1314-1321. PubMed ID: 31560837
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
[TBL] [Abstract][Full Text] [Related]
40. Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.
Pallin M; Walsh S; O'Driscoll MF; Murray C; Cahalane A; Brown L; Carter M; Mitchell P; McDonnell TJ; Butler MW
Lung; 2012 Dec; 190(6):621-8. PubMed ID: 23064487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
